The prolonged tumor-free survival and time to ethical endpoint observed for mice bearing GJB3-depleted TN-MYCLow xenografts, which in vitro were less sensitive to gap junction inhibition than TN-MYCHigh cell lines, imply an additional tumor-intrinsic role for Cx31 as well. The gene discussed is GJB3; the disease is neoplasm.